|
1. Baldessarini RJ. Depression and Mania. In: Brunton L, Chabner B, Knollman B. Goodman and Gilman's the Pharmacological Basis of therapeutics. 20th ed. New York: Mc Graw Hill. 2001; pp: 431-59. 2. Carvalho AF, Berk M, Hyphantis TN, McIntyre RS. The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom. 2014; 83(2): 70-88. doi: 10.1159/000357500 3. Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav. 2013; 118: 227-39. doi: 10.1016/j.physbeh.2013.05.012 4. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002 Dec; 958(2): 439-47. 5. Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM, et al. Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci. 2011 Jan; 1215:103-8. doi: 10.1111/j.1749-6632.2010.05865.x 6. Jacobson JM. The relationship between social support and depression in adolescents. J Child Adolesc Psychiatr Nurs. 1991 Jan; 4(1): 20-24. doi: 10.1111/j.1744-6171.1991.tb00481.x 7. Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, et al. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol. 2010 Jun; 20(6):405-13. doi: 10.1016/j.euroneuro.2010.02.013 8. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl). 2008 Dec;201(3):435-42. doi: 10.1007/s00213-008-1300-y 9. Kulkarni S, Dhir A, Akula KK. Potentials of curcumin as an antidepressant. Scientific World Journal. 2009 Nov; 9:1233-41. doi: 10.1100/tsw.2009.137 10. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol. 2005 Jul; 518(1):40-6. 11. Yu Y, Wang R, Chen C, Du X, Ruan L, Sun J, et al. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences. J Psychiatr Res. 2013 Mar; 47(3):315-22. doi: 10.1016/j.jpsychires.2012.10.018 12. Huang W, Chen Z, Wang Q, Lin M, Wu S, Yan Q, et al. Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. Metab Brain Dis. 2013 Dec; 28(4):585-95. doi: 10.1007/s11011-013-9426-y 13. Wang Z, Gu J, Wang X, Xie K, Luan Q, Wan N, et al. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol Biochem Behav. 2013 Nov; 112:104-10. doi: 10.1016/j.pbb.2013.10.007 14. Huang J, Tufan T, Deng M, Wright G, Zhu MY. Corticotropin releasing factor up-regulates the expression and function of norepinephrine transporter in SK-N-BE (2) M17 cells. J Neurochem. 2015 Oct; 135(1):38-49. doi: 10.1111/jnc.13268 15. Satoh N, Toyohira Y, Takahashi K, Yanagihara N. Effects of various pharmacological agents on the function of norepinephrine transporter. J UOEH. 2015 Mar; 37(1):33-42. doi: 10.7888/juoeh.37.33 16. Matchkov VV, Kravtsova VV, Wiborg O, Aalkjaer C, Bouzinova EV. Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. Am J Physiol Regul Integr Comp Physiol. 2015 Oct; 309(8):R814-23. doi: 10.1152/ajpregu.00337.2014 17. Ge L, Zhu MM, Yang JY, Wang F, Zhang R, Zhang JH, et al. Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. Pharmacol Biochem Behav. 2015 Apr; 131:77-86. doi: 10.1016/j. pbb.2015.01.017
|
